Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DCOYthis companyDecoy Therapeutics Inc.	$1.10	-0.3×	0.64×	0×	0.56×	1723.2%	0.0%	0.0%	0.0%	-212.6%	-214.2%	-128.7%	0×	0.86×	0×	2.13×	0.0%	2	-20.11	2	B-
ENVBEnveric Biosciences, Inc.	$1.45	-0.1×	0.29×	0×	0.4×	755.2%	0.0%	0.0%	0.0%	-290.4%	-210.0%	-670.1%	0×	0.55×	-82,777.81×	5.38×	0.0%	2	-16.31	2	B-
GTBPGT Biopharma, Inc.	$4.35	-0.13×	0.75×	0×	0.09×	542.7%	0.0%	0.0%	0.0%	-490.0%	-214.7%	-298.3%	0×	0.24×	-97.81×	3.5×	5.3%	1	-186.26	2	C
INDPIndaptus Therapeutics, Inc.	$3.16	-0.13×	0.89×	0×	0.27×	149.5%	0.0%	0.0%	0.0%	-661.5%	-629.3%	-527.3%	0×	0.41×	0×	1.51×	0.0%	2	347.9	2	C
REVBRevelation Biosciences, Inc.	$4.10	-0.13×	0.22×	0×	0.88×	2467.3%	0.0%	0.0%	0.0%	-100.6%	-94.4%	-416.3%	0.08×	1.1×	0×	5.41×	0.0%	1	-11.02	2	B-
Peer median	—	-0.13×	0.52×	0×	0.34×	649.0%	0.0%	0.0%	0.0%	-390.2%	-212.3%	-471.8%	0×	0.48×	-48.91×	4.44×	0.0%	2	-13.66	2	—